Table S3 from Attenuation of SRC Kinase Activity Augments PARP Inhibitor–mediated Synthetic Lethality in <i>BRCA2</i>-altered Prostate Tumors

Abstract

&lt;p&gt;Table S3&lt;/p&gt;